Translational Development Acquisition Corp. financial data

Symbol
TDAC, TDACU, TDACW on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 105% %
Debt-to-equity -105% %
Return On Equity -79% %
Return On Assets 2.7% %

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 0 shares
Entity Public Float $0 USD

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $213,658 USD 249%
Operating Income (Loss) $915,583 USD -249%
Nonoperating Income (Expense) $1,873,780 USD
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $4,758,494 USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $47,150 USD
Assets, Current $80,582 USD
Assets $179,979,659 USD
Accounts Payable, Current $16,189 USD 1193%
Liabilities, Current $422,845 USD
Liabilities $6,460,345 USD
Retained Earnings (Accumulated Deficit) $6,380,229 USD
Stockholders' Equity Attributable to Parent $6,379,763 USD -1018%
Liabilities and Equity $179,979,659 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $231,574 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $47,150 USD -79%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares
Unrecognized Tax Benefits $0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares